Universe Pharmaceuticals Inc Asset Resilience Ratio
Universe Pharmaceuticals Inc asset resilience ratio. Universe Pharmaceuticals Inc (UPC) has an Asset Resilience Ratio of 5.11% as of June 2024. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. See Universe Pharmaceuticals Inc defensive liquidity buffer to measure how many days the company can operate on defensive assets alone.
Liquid Assets
Total Assets
Resilience Assessment
Asset Resilience Ratio of Universe Pharmaceuticals Inc (2020–2023)
Asset resilience ratio of Universe Pharmaceuticals Inc from 2020 to 2023. This chart shows how Universe Pharmaceuticals Inc's Asset Resilience Ratio has changed over time. Read Universe Pharmaceuticals Inc (UPC) total liabilities for a breakdown of total debt and financial obligations.
Liquid Assets Composition Over Time
This chart breaks down Universe Pharmaceuticals Inc's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For the complete balance sheet picture, see Universe Pharmaceuticals Inc assets under control.
Current Liquid Assets Breakdown
| Component | Amount | % of Total Assets |
|---|---|---|
| Cash & Equivalents | $0.00 | 0% |
| Short-term Investments | $2.53 Million | 5.11% |
| Total Liquid Assets | $2.53 Million | 5.11% |
Asset Resilience Insights
- Limited Liquidity: Universe Pharmaceuticals Inc maintains only 5.11% of assets in liquid form.
- This low level may indicate efficient asset utilization but could pose risks during economic downturns.
- The company has significant short-term investments, indicating active treasury management.
Universe Pharmaceuticals Inc Industry Peers by Asset Resilience Ratio
Compare Universe Pharmaceuticals Inc's asset resilience ratio with other companies in the same industry.
| Company | Industry | Asset Resilience Ratio |
|---|---|---|
|
Takeda Pharmaceutical Company Limited
F:TKDA |
Drug Manufacturers - Specialty & Generic | 0.69% |
|
Galderma Group N
SW:GALD |
Drug Manufacturers - Specialty & Generic | 3.56% |
|
Enzymatica publ AB
ST:ENZY |
Drug Manufacturers - Specialty & Generic | 22.17% |
|
Shijiazhuang Yiling Pharmaceutical Co Ltd
SHE:002603 |
Drug Manufacturers - Specialty & Generic | 9.04% |
|
Hubei Jumpcan Pharmaceutical Co Ltd
SHG:600566 |
Drug Manufacturers - Specialty & Generic | 47.16% |
|
Kangmei Pharmaceutical Co Ltd
SHG:600518 |
Drug Manufacturers - Specialty & Generic | 0.00% |
|
Walvax BioTech
SHE:300142 |
Drug Manufacturers - Specialty & Generic | 2.20% |
|
Shandong Buchang Pharmaceuticals Co Ltd
SHG:603858 |
Drug Manufacturers - Specialty & Generic | 3.47% |
Universe Pharmaceuticals Inc Asset Resilience Ratio by Year (2020–2023)
Universe Pharmaceuticals Inc asset resilience ratio by year from 2020 to 2023. The table below shows the annual Asset Resilience Ratio data for Universe Pharmaceuticals Inc.
| Year | Asset Resilience Ratio (%) | Liquid Assets | Total Assets | Change |
|---|---|---|---|---|
| 2023-09-30 | 24.81% | $13.22 Million | $53.29 Million | +2.72pp |
| 2022-09-30 | 22.08% | $13.15 Million | $59.54 Million | +2.52pp |
| 2021-09-30 | 19.57% | $13.73 Million | $70.14 Million | -- |
| 2020-09-30 | 0.00% | $0.00 | $28.80 Million | -- |
About Universe Pharmaceuticals Inc
Universe Pharmaceuticals INC, through its subsidiaries, engages in the manufacturing, marketing, distribution, and sales of traditional Chinese medicine derivative products in China. The company offers products for the treatment and relief of common chronic health conditions in the elderly for physical wellness and longevity; and cold and flu medications. It also provides guben yanling, shenrong … Read more